Literature DB >> 10223750

Peritoneal irrigation with povidone-iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model.

S W Lee1, N R Gleason, M Bessler, R L Whelan.   

Abstract

PURPOSE: The development of port-wound tumor recurrences has raised questions regarding the safety of laparoscopic methods for the resection of malignancies. The cause and the incidence of abdominal-wall tumor recurrences remain unknown. It is also not clear how to avoid or lower the incidence of port-tumor recurrences. The purpose of the current study was to determine the impact of abdominal irrigation with povidone-iodine on the port-wound tumor incidence in a murine model.
METHODS: A splenic tumor model was used for this study. To establish splenic tumors, female BALB/c mice (N = 48) were given subcapsular splenic injections of a 0.1 ml suspension containing 10(5) C-26 colon adenocarcinoma cells via a left-flank incision at the initial procedure. Seven days later, the animals with isolated splenic tumors (100 percent) were randomly assigned to one of three groups: 1) control, 2) saline irrigation (saline), or 3) povidone-iodine irrigation. All animals underwent laparoscopic mobilization of the spleen using a three-port technique, intra-abdominal crushing of the tumor, followed by an extracorporeal splenectomy via a subcostal incision. No irrigation was performed for control group animals. In the saline irrigation group, the subcostal incision was closed and pneumoperitoneum was re-established. The abdominal cavity was irrigated with 5 ml of normal saline for 60 seconds before instrument removal. In the povidone-iodine irrigation group, similar abdominal irrigation was performed, using 0.25 percent povidone-iodine. Attempts were made to recover completely the irrigation for both irrigation groups. Seven days after the splenectomy, animals were killed and inspected for abdominal-wall tumor implants.
RESULTS: There were significantly more animals with at least one port-tumor recurrence in the control group than in the povidone-iodine group (P = 0.007). Although not statistically significant, the number of animals with port-wound tumors was higher in the saline group than in the povidone-iodine group (P < 0.08). There was no significant difference between the saline group and the control group. When each port site was considered independently, the incidence of port-wound tumors (number of ports with tumors per total number of ports) was significantly lower in the povidone-iodine group than in both the control (P = 0.00001) and saline groups (P = 0.03). The incidence of port-wound tumors was also significantly lower in the saline group compared with the control group incidence (P = 0.03).
CONCLUSIONS: Abdominal irrigation with dilute povidone-iodine solution significantly reduced the number of animals with port-tumor recurrences. Abdominal irrigation with saline was also effective in reducing the incidence of port-wound tumor formation when each port was considered separately. However, povidone-iodine irrigation was much more effective than saline irrigation in preventing port-wound tumor formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223750     DOI: 10.1007/bf02236346

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Tumor implantation at laparoscopy. Is it a real problem.

Authors:  M Bessler
Journal:  Surg Endosc       Date:  1998-11       Impact factor: 4.584

3.  SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer.

Authors:  Marc Zerey; Lisa Martin Hawver; Ziad Awad; Dimitrios Stefanidis; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2012-12-13       Impact factor: 4.584

4.  Development of port-site metastasis after pneumoperitoneum.

Authors:  Y Hirabayashi; K Yamaguchi; N Shiraishi; Y Adachi; H Kitamura; S Kitano
Journal:  Surg Endosc       Date:  2002-02-08       Impact factor: 4.584

5.  Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice.

Authors:  Patrick Favoulet; Laurent Benoit; Liliana Osmak; Emmanuel Polycarpe; Philippe Esquis; Christian Duvillard; Boris Guiu; Patrick Rat; Jean Pierre Favre; Bruno Chauffert
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

Review 6.  Trocar site recurrence in laparoscopic surgery for colorectal cancer.

Authors:  O Zmora; P Gervaz; S D Wexner
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

Review 7.  Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES).

Authors:  R Veldkamp; M Gholghesaei; H J Bonjer; D W Meijer; M Buunen; J Jeekel; B Anderberg; M A Cuesta; A Cuschierl; A Fingerhut; J W Fleshman; P J Guillou; E Haglind; J Himpens; C A Jacobi; J J Jakimowicz; F Koeckerling; A M Lacy; E Lezoche; J R Monson; M Morino; E Neugebauer; S D Wexner; R L Whelan
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

8.  Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study.

Authors:  M Pross; H Lippert; G Nestler; R Kuhn; H Langer; R Mantke; H-U Schulz
Journal:  Int J Colorectal Dis       Date:  2003-09-03       Impact factor: 2.571

Review 9.  Laparoscopic resection of curable colon and rectal cancer: an evidence-based review.

Authors:  T M Young-Fadok; R D Fanelli; R R Price; D B Earle
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 3.453

10.  Topical treatment with oxaliplatin for the prevention of port-site metastases in laparoscopic surgery for colorectal cancer.

Authors:  Yun-Sheng Tai; Federico Cuenca Abente; Ahmad Assalia; Kazuki Ueda; Michel Gagner
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.